Renee Soto

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) has fought back recently against accusations of spiking inventory levels. A build in inventory levels could ultimately result in production or pricing cuts. A new investigation into Valeant’s operations in Poland reveals some potentially troubling...